
Our medical experts are ready to answer your questions and guide you through your treatment options.
Patients from the UAE facing complex cancer diagnoses often grapple with significant concerns. The pursuit of highly specialized treatments like Immunotherapy and CAR-T Cell Therapy brings questions about access, expertise, and the overall quality of care available internationally. Many seek advanced options beyond their immediate borders.
For those considering options abroad, Hyderabad has emerged as a compelling destination. It offers a unique combination of specialized oncology centers and a coordinated care environment. This city’s medical infrastructure is designed to cater to international patients seeking innovative cancer treatments, streamlining their entire journey.
The trust in Hyderabad's medical capabilities stems from its world-class hospitals and highly skilled specialists. The city is recognized for integrating cutting-edge technology with patient-centric approaches. This ensures that follow-ups and comprehensive care coordination remain seamless, even for patients traveling from the UAE.
Could Hyderabad be the right destination for your advanced cancer treatment?
Immunotherapy is a groundbreaking cancer treatment that harnesses the body's own immune system to identify and destroy cancer cells. Unlike chemotherapy, it doesn't directly attack the cancer but rather empowers the immune system. CAR-T (Chimeric Antigen Receptor T-cell) Cell Therapy is a specific type of immunotherapy where a patient's T-cells are genetically modified in a lab to better recognize and fight cancer, then reinfused into the patient. Both represent significant advancements in oncology, offering new hope for many.
Checkpoint Inhibitors: Block proteins that prevent immune cells from attacking cancer.
Monoclonal Antibodies: Target specific markers on cancer cells or boost immune response.
Oncolytic Viruses: Genetically modified viruses that infect and destroy cancer cells while stimulating the immune system.
CAR-T Cell Therapy: Customizes T-cells to specifically target cancer cells, primarily for blood cancers.
The precise procedure for these therapies depends on the specific cancer type, stage, and the chosen treatment plan for each patient.
Immunotherapy typically involves intravenous infusions administered in cycles over several weeks or months. The specific drug and schedule are tailored to the patient’s diagnosis and response. Patients visit the hospital for each infusion session, which can last from minutes to a few hours.
CAR-T cell therapy is a more complex multi-step process. It begins with leukapheresis, where blood is drawn to collect T-cells. These T-cells are then sent to a specialized lab for genetic modification, where they are engineered to express chimeric antigen receptors (CARs). While the cells are being modified (a process that takes several weeks), the patient may undergo bridging chemotherapy. Before infusion, patients receive lymphodepleting chemotherapy to prepare their body. Finally, the modified CAR-T cells are infused back into the patient, typically requiring a hospital stay for close monitoring due to potential side effects.
Recovery from immunotherapy and CAR-T cell therapy varies greatly. Immunotherapy recovery often involves managing side effects, which can range from fatigue and skin rashes to more serious autoimmune reactions. For CAR-T therapy, patients require intensive monitoring in the hospital for weeks after infusion for potential complications like cytokine release syndrome (CRS) and neurological toxicities. Long-term follow-up and management of late-onset side effects are crucial for both types of treatment.
The success rates for Immunotherapy and CAR-T Cell Therapy are highly variable, depending on the type of cancer, its stage, and the individual patient's health and response. These treatments offer significant promise, especially for cancers that have not responded to conventional therapies, with some patients achieving long-term remissions. Outcomes are continuously improving with ongoing research and clinical advancements.
The cost of advanced cancer treatments like Immunotherapy and CAR-T Cell Therapy in Hyderabad is significantly more competitive than in many Western nations. Several factors influence the final cost, including the specific type of immunotherapy or CAR-T product used, the hospital chosen, the duration of treatment, and any additional medications or supportive care required.
For Immunotherapy, costs in Hyderabad can range from INR 15,00,000 to INR 35,00,000 per cycle or course. CAR-T Cell Therapy, being a highly specialized and complex procedure, ranges from INR 1,50,00,000 to INR 3,00,00,000.
Hyderabad offers a significant cost advantage while maintaining high standards of medical care for these cutting-edge therapies.
| Treatment Type | Hyderabad (INR) | USA (USD) | UK (GBP) | Singapore (SGD) | Germany (EUR) |
|---|---|---|---|---|---|
| Immunotherapy (per course) | 15,00,000 - 35,00,000 | $150,000 - $300,000 | £120,000 - £250,000 | $180,000 - $350,000 | €140,000 - €280,000 |
| CAR-T Cell Therapy (full course) | 1,50,00,000 - 3,00,00,000 | $500,000 - $1,000,000+ | £350,000 - £700,000+ | $600,000 - $1,200,000+ | €450,000 - €900,000+ |
Ready to explore advanced treatment options in Hyderabad? Contact us for a personalized treatment plan and cost estimate.
Choosing the right path for advanced cancer treatment is a significant decision. Hyderabad offers a blend of expertise, technology, and compassionate care to support you through every step of this journey.
Connect with our expert team today to understand how we can facilitate your treatment in Hyderabad.
India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.
Meet our team of highly qualified and experienced medical professionals dedicated to providing the best healthcare services.
Get Personalized Medical Treatment Options From India's Top Hospitals. Our Medical Experts Are Ready To Assist You Every Step Of The Way.